Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEAT-HFpeF
NCT02053493Phase 2Completed
- Start
- Apr 2014
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of isosorbide mononitrate in heart failure with preserved ejection fraction (HFpEF). Started Apr 2014; status: completed.
02
Drugs
isosorbide mononitrate
03
Conditions
heart failure with preserved ejection fraction (HFpEF)
Beyond the preview
Go deeper on NCT02053493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02053493.